You just read:

Provention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease

News provided by

Provention Bio, Inc.

Apr 24, 2019, 07:00 ET